Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 1 mg - capsule, hard - excipient ingredients: hypromellose; gelatin; ethanol absolute; lactose; titanium dioxide; purified water; magnesium stearate; methyl chloride; croscarmellose sodium; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 0.5 mg - capsule, hard - excipient ingredients: ethanol absolute; gelatin; croscarmellose sodium; purified water; iron oxide yellow; magnesium stearate; titanium dioxide; methyl chloride; lactose; hypromellose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 0.5 mg - capsule, hard - excipient ingredients: gelatin; magnesium stearate; titanium dioxide; methyl chloride; iron oxide yellow; hypromellose; purified water; lactose; croscarmellose sodium; ethanol absolute; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 5 mg - capsule, hard - excipient ingredients: hypromellose; titanium dioxide; ethanol absolute; gelatin; purified water; magnesium stearate; lactose; croscarmellose sodium; methyl chloride; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 0.5 mg - capsule, hard - excipient ingredients: gelatin; croscarmellose sodium; titanium dioxide; methyl chloride; iron oxide yellow; ethanol absolute; hypromellose; lactose; purified water; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 5 mg - capsule, hard - excipient ingredients: croscarmellose sodium; magnesium stearate; ethanol absolute; gelatin; hypromellose; lactose; purified water; titanium dioxide; methyl chloride; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 5 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; lactose; methyl chloride; titanium dioxide; hypromellose; magnesium stearate; ethanol absolute; purified water; croscarmellose sodium; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 1 mg - capsule, hard - excipient ingredients: methyl chloride; gelatin; magnesium stearate; purified water; ethanol absolute; hypromellose; titanium dioxide; croscarmellose sodium; lactose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 1 mg - capsule, hard - excipient ingredients: gelatin; methyl chloride; magnesium stearate; croscarmellose sodium; lactose; hypromellose; ethanol absolute; purified water; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - amiodarone hydrochloride, quantity: 150 mg - injection, solution - excipient ingredients: polysorbate 80; water for injections; benzyl alcohol; hydrochloric acid; sodium hydroxide - severe cases of tachyarrhythmias (eg. wolff-parkinson-white syndrome, supraventricular, nodal and ventricular tachyardias, atrial flutter and fibrillation, ventricular fibrillation) not responding to other therapy. treatment should be initiated in hospital. it is recommended that the patient should be regularly monitored for possible toxicity (eg. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation.,amiodarone hhh injection may be used for treatment initiated in a hospital for severe cases of tachyarrhythmias (atrial, junctional and ventricular) not responding to other therapy and when a rapid response is required. amiodarone hhh injection should only be used where facilities exist for cardiac monitoring and defibrillation should the need arise.